businesspress24.com - Biotech: Pressemitteilungen - Kategorie - Seite 189
 

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Peregrine Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2012 Financial Results and Recent Developments

TUSTIN, CA: Exceptional Data From Bavituximab Proof-of-Concept Phase II Trial in Second-Line NSCLC Validates Platform and Positions Program for Phase III Development; Wholly-Owned Subsidiary Reports Record Revenu ...

Peregrine Announces Initiation of a Phase I Rectal Adenocarcinoma Investigator-Sponsored Trial

TUSTIN, CA and DALLAS, TX: Fifth IST to Evaluate Bavituximab's Broad Therapeutic Potential for Oncology Indications ...

Coferon, Inc. Announces $12 Million Series B Financing

STONY BROOK, NY: Appoints Dr. Colin Goddard as Chairman and Chief Executive Officer ...

COTI Reports on Operational Successes and Financial Results

LONDON, ONTARIO: For the Fourth Quarter and the Year Ended April 30, 2012 ...

AVI BioPharma Announces Corporate Name Change to Sarepta Therapeutics and Stock Ticker Symbol Change to "SRPT" Effective Today

BOTHELL, WA: Enacts Reverse Stock Split to Strengthen Financial Base; Reaffirms Commitment to Accelerate Development of First-in-Class RNA-Based Therapies for Serious and Life-Threatening Rare and Infectious Disea ...


Page 189 von 247:  « ..  188 189 190  191  192  193  194  195  196  197  .. » 247





 

Who is online

All members: 10 567
Register today: 2
Register yesterday: 0
Members online: 0
Guests online: 95


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.